Viridian Therapeutics所有资讯

Viridian Therapeutics | 10-Q：季度报表

05/08 19:53

Viridian Therapeutics | 8-K：Viridian Therapeutics重点介绍近期进展并公布2024年第一季度财务业绩

05/08 19:13

Viridian Therapeutics | ARS：年度报告

04/26 20:38

Viridian Therapeutics | DEFA14A：其他

04/26 20:38

Viridian Therapeutics | DEF 14A：股东委托书决议

04/26 20:33

Viridian Therapeutics | 8-K：重大事件

04/17 04:11

Viridian Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(18.64%),Fairmount Healthcare Fund II GP LLC(18.64%)等

04/02 06:43

Viridian Therapeutics | 4：持股变动声明-董事 Fairmount Funds Management LLC

04/02 06:38

Viridian Therapeutics | S-8：员工福利计划证券登记

02/29 11:45

Viridian Therapeutics | 10-K：年度报表

02/28 05:42

Viridian Therapeutics | 8-K：Viridian Therapeutics重点介绍了近期进展并公布了2023年第四季度和全年财务业绩

02/28 05:17

Viridian Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%)等

02/15 09:33

Viridian Therapeutics | 3：首次持股声明-高管 Tousignant Jennifer

02/15 07:06

Viridian Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Commodore Capital LP(3.7%),Commodore Capital Master LP(3.7%)

02/15 07:05

Viridian Therapeutics | 4：持股变动声明-高管 Tousignant Jennifer

02/15 07:05

Viridian Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)

02/15 06:53

Viridian Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等

02/14 22:27

Viridian Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Deep Track Capital, LP(9.90%),Deep Track Biotechnology Master Fund, Ltd.(9.90%)等

02/14 22:02

Viridian Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(5.71%)

02/14 11:30

Viridian Therapeutics | 4：持股变动声明-高管 Ciulla Thomas

02/08 05:02